Daniel Howell, DPM
Foot & Ankle Surgery · Roseburg, ORNPI 1972025450
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Steelhead Surgical Inc at 52.4% of the total. Reporting peaked in 2022 at $1,221 and has fallen 98.9% since, to $14 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in OR, where the typical reported total is $2,664.
Across 19 payments — averaging $121.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$1K
- Treace Medical Concepts, Inc.$879
- Advanced Oxygen Therapy Inc.$90
- AbbVie$35
- Innovation Technologies Inc$33
- Melinta Therapeutics, LLC$31
- plus $28 from 2 others
What the payments were for
- Travel & lodging$52523%
- Food & beverage$57725%
- Education$1,20052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 2 | $1,205 |
| Treace Medical Concepts, Inc. | 9 | $879 |
| Advanced Oxygen Therapy Inc. | 1 | $90 |
| AbbVie(2 entities) | 2 | $35 |
| Innovation Technologies Inc | 1 | $33 |
| Melinta Therapeutics, LLC | 2 | $31 |
| Integra Lifesciences Corporation | 1 | $14 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,301 in reported general payments places this provider in the 45th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 17 | $314 |
| Minocycline Hcl | 29 | $237 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $219 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $154 |
| Mupirocin | 12 | $140 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $109 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $45 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Roseburg
- Natalie MesnierPortland$339K
- Stephen WallaceLake Oswego$205K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Cassandra TomczakTualatin$73K
- Akash GuptaMilwaukie$40K
- Timothy MineoGresham$25K
- Justin BrohardSalem$24K
- Trevor HaynesSandy$21K
- Kevin DriscollPortland$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.